Skip to main content
Explore URMC

URMC Logo

menu
URMC / Research / Research@URMC
Gene Study Points Researchers toward New Pathway for Leukemia

Gene Study Points Researchers toward New Pathway for Leukemia

Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.

5/8/2017
What rare diseases do we study at URMC?

What rare diseases do we study at URMC?

Rare diseases affect approximately 25 million people in the U.S., but less than 5 percent of these illnesses have a treatment. With the help of patients and their families, physicians and scientists at the University of Rochester Medical Center are working to change that. 

2/29/2016
Hematology Event Draws Wilmot Scientists, New Data

Hematology Event Draws Wilmot Scientists, New Data

Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is attended by more than 20,000 clinicians and scientists.

12/5/2013
Lab Pinpoints New Drug Target for Infant Leukemia

Lab Pinpoints New Drug Target for Infant Leukemia

Although many childhood leukemias are curable, one type – known as 11q23 infant leukemia – has a poor survival rate and requires intensive treatment with life-threatening side effects. In an early-edition article in Blood, the URMC shows it discovered a gene that could provide a new target for therapy.

9/10/2013